Molecular Markers and Potential Therapeutic Targets in Non-WNT/Non-SHH (Group 3 and Group 4) Medulloblastomas

Journal of Hematology and Oncology - United Kingdom
doi 10.1186/s13045-019-0712-y
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Molecular Subgroups of Medulloblastoma: An International Meta-Analysis of Transcriptome, Genetic Aberrations, and Clinical Data of WNT, SHH, Group 3, and Group 4 Medulloblastomas

Acta Neuropathologica
Forensic MedicineMolecular NeurosciencePathologyNeurologyCellular
2012English

Downregulation of miR-204 Expression Defines a Highly Aggressive Subset of Group 3/Group 4 Medulloblastomas

Acta neuropathologica communications
Forensic MedicineMolecular NeurosciencePathologyNeurologyCellular
2019English

Deep Sequencing of WNT-activated Medulloblastomas Reveals Secondary SHH Pathway Activation

Acta Neuropathologica
Forensic MedicineMolecular NeurosciencePathologyNeurologyCellular
2018English

Second-Generation Molecular Subgrouping of Medulloblastoma: An International Meta-Analysis of Group 3 and Group 4 Subtypes

Acta Neuropathologica
Forensic MedicineMolecular NeurosciencePathologyNeurologyCellular
2019English

Lipid Profile in RDS Group and Non-RDS Group: A Comparison Study

Journal of Evolution of Medical and Dental Sciences
2015English

SNCA , a Novel Biomarker for Group 4 Medulloblastomas, Can Inhibit Tumor Invasion and Induce Apoptosis

Cancer Science
Cancer ResearchMedicineOncology
2018English

Non-Coding RNAs in Cardiac FIbrosis: Emerging Biomarkers and Therapeutic Targets

Cardiology Journal
MedicineCardiovascular MedicineCardiology
2013English

Table 1: Demographics Between Kawasaki Disease Group and Non-Kawasaki Disease Group.

English

Preliminary Exploration of Potential Molecular Therapeutic Targets in Recurrent and Metastatic Parathyroid Carcinomas

International Journal of Cancer
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy